Podcast Episodes
Back to Search
New Hampshire’s Hot News & Headlines | Concord News
New Hampshire’s schools are under pressure as 70% of funding comes from property taxes, but the University of New Hampshire is easing the burden…
1 day, 5 hours ago
New Hampshire Schools Face Hunger, STEM Boost, and Accountability Scrutiny | Concord News
New Hampshire faces a looming crisis as thousands of students may lose access to free school lunches amid tightening SNAP rules—while the Univer…
1 day, 5 hours ago
Felix Poon’s Curious World of Audio | Concord News
Felix Poon is redefining podcast storytelling with his sharp, curiosity-driven work on Outside/In, where he transforms complex topics—from toxic…
1 day, 5 hours ago
Investing in Trusted News for the Future | Concord News
Sarah Alger, NHPR’s new Director of Major and Planned Gifts, brings big-name fundraising experience from Chicago’s Newberry Library and top hosp…
1 day, 5 hours ago
Clancy Trial Focuses on Mental Health | Concord News
The trial of Lindsay Clancy, accused of murdering her three children in 2023, intensifies as prosecutors detail the chilling events leading to t…
1 day, 6 hours ago
Concord Weather: Sunny with a Storm | Concord News
This week in Concord is heating up with temps in the low to upper 80s and mostly sunny skies—perfect for outdoor plans—until Thursday, when a th…
1 day, 6 hours ago
Planet Hits Record Heat | Concord News
Earth just shattered its hottest temperature record — and it’s not a fluke. The planet’s average temperature has officially hit a new peak, mark…
1 day, 6 hours ago
Weight Loss Drugs Lose Their Edge | Concord News
A new study reveals that most people using weight-loss drugs like Ozempic and Wegovy regain nearly two-thirds of their lost weight within a year…
1 day, 6 hours ago
AI Model Pulled for Accuracy Fixes | Concord News
A major tech giant has pulled the plug on its new AI model after uncovering serious flaws—historical inaccuracies and harmful stereotypes—that s…
1 day, 7 hours ago
FDA Approves First Alzheimer’s Drug in Years | Concord News
FDA just greenlit lecanemab, the first drug in years to target Alzheimer’s amyloid plaques — offering hope to early-stage patients by slowing co…
1 day, 8 hours ago